Keywords: tysabri, backing, uk, nice, milestone, britain, underdeveloped

Tysabri backing by UK's NICE a milestone for Britain's underdeveloped MS market

Article | 30 July 2007

Print This

The decision by the National Institute for Health and Clinical Excellence (NICE), the body that recommends treatments to be made ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in